• EZ Cap™ Firefly Luciferase mRNA: Delivery Calibrator

  2026-08-23

  EZ Cap™ Firefly Luciferase mRNA can serve as more than a reporter: it is a standardized payload for separating delivery, endosomal escape, translation, and assay variability. This article connects Cap 1 mRNA design with rational lipid nanoparticle screening and in vivo bioluminescence imaging.

• iRhom2, Odorant Receptors, and Olfactory Adaptation

  2026-08-22

  Azzopardi and colleagues identify iRhom2 as a distinctive regulator of olfactory sensory neurons, linking odorant receptor signaling with ADAM17-dependent activity adaptation. Their combination of knockout mice, transcriptomics, spatial validation, and a receptor activation model suggests a feedback mechanism in which odor exposure reduces iRhom2 expression while reshaping receptor- and activity-related transcription.

• Sulfachloropyridazine: Applied Research Workflows

  2026-08-21

  Sulfachloropyridazine supports mechanistic DHPS studies, antimicrobial susceptibility testing, combination-antibiotic experiments, and microbiome-focused infection research. This workflow-oriented guide connects controlled bench assays with the integrated microbiota and metabolomics strategy used in Eimeria-infected chickens.

• Caffeine Workflows for Cancer and Metabolic Research

  2026-08-21

  Caffeine supports controlled studies of cancer cell line inhibition, energy metabolism modulation, and hypothalamic signaling, with practical solubility advantages for aqueous workflows. This guide pairs dose-response design and troubleshooting with a clearly bounded translation of ALDH2 activator research into better assay strategy.

• Safe DNA Gel Stain for RNA Workflows

  2026-08-20

  Safe DNA Gel Stain supports sensitive DNA and RNA gel analysis while enabling blue-light visualization that can help protect samples destined for cloning or sequencing. This practical guide connects routine gel quality control with advanced RNA-structure workflows, including the cgSHAPE-seq strategy used to map ligand binding in SARS-CoV-2 RNA.

• EZ Cap™ Cy5 EGFP mRNA: Delivery Workflow

  2026-08-20

  Build a quantitative mRNA delivery and translation efficiency assay around one reporter that separates cellular uptake from functional EGFP expression. The dual-fluorescence design supports nanoparticle screening, macrophage-focused delivery studies, and troubleshooting of intracellular trafficking without relying on secondary labeling.

• Deferasirox Fe3+ Chelate for Iron Research

  2026-08-19

  Build reproducible iron-binding, cell-response, and translational assays with Deferasirox Fe3+ chelate, while accounting for its pre-formed ferric complex and DMSO-dependent handling. The workflow connects Exjade-related clinical evidence with practical beta-thalassemia iron chelation and chronic anemia iron management experiments.

• From Diuron Signals to qPCR Translation

  2026-08-19

  A translational framework for using SYBR Green qPCR to validate diuron-associated osteotoxicity signals, connect BMSC phenotypes with PI3K/Akt biology, and build more reproducible environmental toxicology workflows with HotStart™ 2X Green qPCR Master Mix.

• MRT68921 ULK1 Kinase Inhibitor: Workflow Guide

  2026-08-18

  MRT68921 enables controlled, pathway-level autophagy inhibition by targeting both ULK1 and ULK2, making it useful for dissecting initiation signals, energy-stress responses, and LC3 flux. This practical guide covers dosing design, ATG13 phosphorylation blockade, assay controls, and troubleshooting for reproducible cell-based studies.

• Sex Differences in Angiotensin II Hypertension

  2026-08-17

  This reference study used telemetry in conscious, freely moving mice to show that chronic angiotensin II produces a substantially greater hypertensive response in males than females. Gonadectomy, baroreflex testing, and ganglionic blockade further implicated sex hormones and sympathetic regulation, providing a useful framework for sex-aware cardiovascular study design.

• Marein Inhibits ABCG2 and Restores Chemosensitivity

  2026-08-17

  The reference study identifies marein, a flavonoid from Coreopsis tinctoria Nutt, as a competitive inhibitor of the ABCG2 drug efflux transporter. By increasing intracellular exposure to ABCG2-substrate chemotherapeutics and sensitizing resistant cancer cells, the work provides a mechanistic framework for transporter-directed chemosensitization.

• PEI-Modified Laminarin Nanoparticles Boost OVA Vaccination

  2026-08-16

  The reference study develops cationic laminarin nanoparticles by polyethyleneimine modification and uses them to deliver ovalbumin as a model antigen. The formulation improves dendritic-cell uptake, maturation, lysosomal escape, antigen cross-presentation, and downstream humoral and cellular immunity compared with an aluminum adjuvant.

• Small-Molecule LAG-3 Inhibitors: Study Insights

  2026-08-15

  The 2023 ACS Medicinal Chemistry Letters study combines focused screening with SAR by catalog to identify a small molecule that inhibits both LAG-3/MHC class II and LAG-3/FGL1 interactions. Its biochemical and cell-based results establish an early proof of concept for dual LAG-3 blockade, while also defining the selectivity, pharmacology, and translational studies still needed.

• Tacrolimus (FK506) as a Causal Probe of T-Cell Signaling

  2026-08-15

  Tacrolimus (FK506) is more than a potent calcineurin inhibitor: it is a precise causal probe for connecting FKBP12 complex formation to NFAT-dependent cytokine output. This article translates genetic evidence from cyclosporine research into rigorous assay design for transplantation immunology research and autoimmune disease models.

• uPAR–uPA Inhibition in Breast Cancer Metastasis

  2026-08-14

  The reference study advanced compound 4 from a computationally identified protein–protein interaction hit to a chemically synthesized and biologically validated inhibitor of uPAR–uPA signaling. Direct binding, cellular invasion assays, pharmacokinetics, and a murine metastasis model together support compound 4 as a lead template, while also defining important limitations for translation and assay replication.

451 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page